Online Program Home
My Program

Keyword Search

Legend:
CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Keyword Search Criteria: vaccine returned 17 record(s)
Sunday, 07/29/2018
Risk Prediction Through Temporal Phenotyping and Incorporation of MedDRA Information
Yong Chen, University of Pennsylvania; Rui Duan, University of Pennsylvania
5:20 PM

Monday, 07/30/2018
A Hybrid Method for the Stratified Mark-Specific Proportional Hazards Models with Missing Data, with Applications to Dengue Vaccine Efficacy Trials
Yanqing Sun, University of North Carolina At Charlotte; Li Qi, Biostatistics and Programming, Sanofi; Peter Gilbert, Fred Hutchinson Cancer Research Center; Fei Heng, University of North Carolina at Charlotte
9:15 AM

Recent Challenges in Vaccine Clinical Development
Tsai-Lien Lin, FDA/CBER
10:35 AM

Inference on Treatment Effect Modification by Marker Response in a Baseline Surrogate Measure Three-Phase Sampling Design
Michal Juraska, Fred Hutchinson Cancer Research Center; Ying Huang, Fred Hutchinson Cancer Research Center; Peter Gilbert, Fred Hutchinson Cancer Research Center
10:50 AM

Bridging to Bridges in Vaccine Development: Challenges in Comparing Multi-Serotype Vaccines
Jonathan Hartzel, Merck
10:55 AM

Application of Futility Testing in Vaccine Outcome Studies (With a Recent Example)
Aiying Chen, Sanofi Pasteur; Scott Patterson, Sanofi Pasteur; Ehab Bassily, Sanofi Pasteur
11:15 AM

A Unified Approach to the Statistical Evaluation of Differential Vaccine Efficacy
Erin Gabriel, Karolinska Institute; Dean Follmann, NIAID
11:20 AM

An Analysis of MIMIC Data for Potential Surrogate Markers for Vaccine Development
Robert Small, Sanofi Pasteur; Pauline Jurvilliers, Sanofi Pasteur
11:20 AM

Epidemiological Modeling to Guide Efficacy Study Design Evaluating Vaccines to Prevent Emerging Diseases
An Vandebosch, Janssen; Joris Menten, Janssen ; Guillermo Herrera-Taracena, Janssen
11:35 AM

Maximum Diversity Weighting for Biomarkers with Application in HIV-1 Vaccine Studies
Zonglin He, Fred Hutchinson Cancer Research Center; Youyi Fong, Fred Hutchinson Cancer Research Center
11:55 AM

Tuesday, 07/31/2018
Monitoring Vaccine Safety by Studying Temporal Trend of Adverse Events Using VAERS
Jing Huang, University of Pennsylvania; Yi Cai, Pieces Technology; Jingcheng Du, University of Texas Health Science Center; Ruosha Li, University of Texas School of Public Health; Susan S Ellenberg, University of Pennsylvania; Sean Hennessy, University of Pennsylvania; Cui Tao, University of Texas Health Science Center; Yong Chen, University of Pennsylvania
11:35 AM

General Regression Model for the Subdistribution of a Competing Risk Under Left-Truncation and Right-Censoring
Anna Bellach, Fred Hutch Cancer Research Center; Michael Kosorok, University of North Carolina at Chapel Hill; Peter Gilbert, Fred Hutchinson Cancer Research Center; Jason P Fine, University of North Carolina at Chapel Hill
2:35 PM

Wednesday, 08/01/2018
Controlling the Family-Wise Type I Error Rate in a Phase II POC Trial of the Merck Pneumococcal Vaccine Program: An Application of the Hochberg Approach
Jianing Li, Merck Research Lab
9:35 AM

Estimation of Contagion Effects in Households and Other Networks
Forrest W Crawford, Yale School of Public Health; Wen Wei Loh, Ghent University
3:05 PM

Thursday, 08/02/2018
Competing Effects of Indirect Protection and Clustering on the Power of a Cluster-Randomized Controlled Vaccine Trial
Matthew Hitchings, Harvard School of Public Health
10:35 AM

A Bayesian Approach to Sequential Analysis in Post-Licensure Vaccine Safety Surveillance
Rongxia Li, Centers for Disease Control and Prevention
11:35 AM

Evaluating the Ability of a Biomarker to Improve the Diagnosis of Malaria Infection in Malaria 'Challenge' Trials
Holly Janes, Fred Hutchinson Cancer Research Center
11:50 AM